(Q45880972)

17 December 2017

title

Kinetic Aspects of the Removal of IgG and Inhibitors in Hemophiliacs Using Protein A Immunoadsorption (English)

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

20 November 2022

main subject

Staphylococcal Protein A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776241

20 November 2022

Immunoadsorption

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776241

20 November 2022

author name string

P. Gjörstrup

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776241

20 November 2022

E. Berntorp

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776241

20 November 2022

L. Larsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776241

20 November 2022

I. M. Nilsson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776241

20 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1776241

20 November 2022

publication date

1 January 1991

1 reference

17 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1423-0410.1991.tb00954.x

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1423-0410.1991.tb00954.x/fullpdf

20 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

20 November 2022

1 reference

17 December 2017

volume

61

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

244-250

1 reference

17 December 2017

Quantitation of J Chain in Human Biological Fluids by a Simple Immunochemical Procedure

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1991.TB00954.X

Treatment of factor VIII inhibitors

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

Factor VIII inhibitor bypassing activity: a suggested mechanism of action

20 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial

20 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies

20 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial

20 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

Serial plasmapheresis in a haemophiliac with antibodies to FVIII

20 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

Successful preoperative apheresis of factor VIII antibody using factor VIII concentrate as a replacement fluid

20 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies

20 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.

20 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

Polymorphism of normal factor IX detected by mouse monoclonal antibodies

20 November 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX

20 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

Binding of immunoglobulins to protein A and immunoglobulin levels in mammalian sera

20 November 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy

20 November 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00954.X

20 November 2022

Identifiers

1 reference

17 December 2017

1 reference

17 December 2017